Xu Zuo

577 total citations
23 papers, 387 citations indexed

About

Xu Zuo is a scholar working on Epidemiology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xu Zuo has authored 23 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Immunology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xu Zuo's work include Herpesvirus Infections and Treatments (9 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Viral-associated cancers and disorders (5 papers). Xu Zuo is often cited by papers focused on Herpesvirus Infections and Treatments (9 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Viral-associated cancers and disorders (5 papers). Xu Zuo collaborates with scholars based in China, Malaysia and Italy. Xu Zuo's co-authors include Yinuo Gu, Fang Wang, Meili Li, Mingsheng Cai, Tao Peng, Xiaowen Ou, He Pan, Guoqiang Wang, Xiaoping Guo and Caina Xu and has published in prestigious journals such as Advanced Functional Materials, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Xu Zuo

23 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu Zuo China 13 117 107 106 79 79 23 387
Nicolás Oscar Amiano Argentina 14 127 1.1× 102 1.0× 175 1.7× 69 0.9× 47 0.6× 22 482
Gholam Ali Kardar Iran 14 66 0.6× 138 1.3× 254 2.4× 43 0.5× 136 1.7× 54 628
Adele Barugahare Australia 8 120 1.0× 191 1.8× 118 1.1× 54 0.7× 30 0.4× 13 467
Subhashini Arimilli United States 15 99 0.8× 155 1.4× 316 3.0× 30 0.4× 71 0.9× 38 558
C. Guillén United Kingdom 12 39 0.3× 91 0.9× 211 2.0× 72 0.9× 74 0.9× 23 522
Tirthankar Mohanty Sweden 14 73 0.6× 181 1.7× 244 2.3× 80 1.0× 24 0.3× 24 538
Axel Dignaß Germany 8 78 0.7× 192 1.8× 173 1.6× 52 0.7× 111 1.4× 24 605
Tiago da Silva Medina Brazil 12 80 0.7× 186 1.7× 238 2.2× 40 0.5× 151 1.9× 25 573
Zheng Wu China 12 73 0.6× 117 1.1× 63 0.6× 28 0.4× 28 0.4× 20 391

Countries citing papers authored by Xu Zuo

Since Specialization
Citations

This map shows the geographic impact of Xu Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Zuo more than expected).

Fields of papers citing papers by Xu Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Zuo. The network helps show where Xu Zuo may publish in the future.

Co-authorship network of co-authors of Xu Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Zuo. A scholar is included among the top collaborators of Xu Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Zuo. Xu Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Xiaoping, Xu Zuo, Dan Zhao, et al.. (2025). Catalase-encapsulated matrix metalloproteinase-9 responsive nanogels for modulation of inflammatory response and treatment of neutrophilic asthma. Journal of Nanobiotechnology. 23(1). 374–374. 2 indexed citations
2.
Zuo, Xu, Xiaoping Guo, Yinuo Gu, et al.. (2024). A Novel Catalase Nanogels for Effective Treatment of Neutrophilic Asthma. Advanced Functional Materials. 34(32). 13 indexed citations
3.
Zuo, Xu, Yinuo Gu, Xiaoping Guo, et al.. (2024). Preparation of Budesonide-Loaded Liposomal Nanoparticles for Pulmonary Delivery and Their Therapeutic Effect in OVA-Induced Asthma in Mice. International Journal of Nanomedicine. Volume 19. 673–688. 5 indexed citations
5.
Guo, Xiaoping, Xu Zuo, Zhengjie Zhou, et al.. (2023). PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases. International Journal of Molecular Sciences. 24(5). 4333–4333. 56 indexed citations
6.
Zhao, Jie, Yan Liang, Wei Hu, et al.. (2022). Cost-Effectiveness Analysis of PEG-rhG-CSF as Primary Prophylaxis to Chemotherapy-Induced Neutropenia in Women With Breast Cancer in China: Results Based on Real-World Data. Frontiers in Pharmacology. 12. 754366–754366. 6 indexed citations
7.
Zuo, Xu, Xiaoping Guo, Yinuo Gu, et al.. (2022). Recent Advances in Nanomaterials for Asthma Treatment. International Journal of Molecular Sciences. 23(22). 14427–14427. 12 indexed citations
8.
Zhu, Zhenxing, Xu Zuo, He Pan, et al.. (2020). The role of NTHi colonization and infection in the pathogenesis of neutrophilic asthma. Respiratory Research. 21(1). 170–170. 36 indexed citations
9.
Wang, Ping, Yingjie Guo, Xu Zuo, et al.. (2020). Epstein-Barr Virus Early Protein BFRF1 Suppresses IFN-β Activity by Inhibiting the Activation of IRF3. Frontiers in Immunology. 11. 513383–513383. 22 indexed citations
10.
Cai, Mingsheng, Xu Zuo, Tong Li, et al.. (2020). Herpes Simplex Virus 1 UL2 Inhibits the TNF-α–Mediated NF-κB Activity by Interacting With p65/p50. Frontiers in Immunology. 11. 549–549. 18 indexed citations
11.
12.
Chen, Tao, Xu Zuo, Ping Wang, et al.. (2019). Epstein‐Barr virus tegument protein BGLF2 inhibits NF‐κB activity by preventing p65 Ser536 phosphorylation. The FASEB Journal. 33(9). 10563–10576. 34 indexed citations
13.
Zuo, Xu, Xiaowen Ou, Yiwen Li, et al.. (2019). Expression, Purification, and Antiserum Production of the Truncated UL31 Protein of Herpes Simplex Virus 1. Iranian Journal of Biotechnology. 17(1). 74–79. 4 indexed citations
14.
Cai, Mingsheng, Ping Wang, Tao Chen, et al.. (2019). Identification of the molecular determinants for nuclear import of PRV EP0. Biological Chemistry. 400(10). 1385–1394. 12 indexed citations
15.
Li, Meili, Xu Zuo, Yiwen Li, et al.. (2019). The Interaction Mechanism Between Herpes Simplex Virus 1 Glycoprotein D and Host Antiviral Protein Viperin. Frontiers in Immunology. 10. 2810–2810. 18 indexed citations
16.
Zheng, Jingtong, He Pan, Yinuo Gu, et al.. (2019). Prospects for Malaria Vaccines: Pre-Erythrocytic Stages, Blood Stages, and Transmission-Blocking Stages. BioMed Research International. 2019. 1–9. 18 indexed citations
17.
Li, Meili, Xu Zuo, Yiwen Li, et al.. (2019). Intracellular distribution of pseudorabies virus UL2 and detection of its nuclear import mechanism. Biological Chemistry. 401(2). 309–317. 4 indexed citations
18.
Zhang, Chao, Alan Hsu, He Pan, et al.. (2019). Columbianadin Suppresses Lipopolysaccharide (LPS)-Induced Inflammation and Apoptosis through the NOD1 Pathway. Molecules. 24(3). 549–549. 23 indexed citations
19.
Chen, Tao, Xu Zuo, Ping Wang, et al.. (2018). Molecular Characterization of the Epstein-Barr Virus BGLF2 Gene, its Expression, and Subcellular Localization. Iranian Journal of Biotechnology. 16(2). 85–96. 5 indexed citations
20.
Li, Meili, Tao Chen, Xu Zuo, et al.. (2018). Characterization of the Nucleocytoplasmic Transport Mechanisms of Epstein-Barr Virus BFLF2. Cellular Physiology and Biochemistry. 51(4). 1500–1517. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026